Variant report

Variant	nsv589932
Chromosome Location	chr3:21985417-22047934
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:111)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:111 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr3:22021993-22022316	HepG2	liver:	n/a	n/a
2	CEBPB	chr3:22030829-22031267	Hela-S3	cervix:	n/a	chr3:22031068-22031085 chr3:22031049-22031060
3	CEBPB	chr3:22030902-22031215	HepG2	liver:	n/a	chr3:22031068-22031085 chr3:22031049-22031060
4	CEBPB	chr3:22038218-22038531	HepG2	liver:	n/a	chr3:22038377-22038388
5	CEBPB	chr3:22030956-22031213	A549	lung:	n/a	chr3:22031068-22031085 chr3:22031049-22031060
6	CEBPB	chr3:22038225-22038503	IMR90	lung:	n/a	chr3:22038377-22038388
7	CEBPB	chr3:22038239-22038536	A549	lung:	n/a	chr3:22038377-22038388
8	CEBPB	chr3:21996134-21996664	IMR90	lung:	n/a	n/a
9	CEBPB	chr3:21996174-21996533	Hela-S3	cervix:	n/a	n/a
10	CTCF	chr3:21998853-21998886	GM13976	blood:	n/a	n/a
11	CTCF	chr3:21988251-21988325	LNCaP	prostate:	n/a	n/a
12	CTCF	chr3:22000640-22000790	HFF	foreskin:	n/a	n/a
13	CTCF	chr3:22012637-22012708	Lung_OC	lung:	n/a	n/a
14	CTCF	chr3:21996780-21996930	GM06990	blood:	n/a	n/a
15	E2F4	chr3:22033650-22033821	MCF10A-Er-Src	breast:	n/a	n/a
16	E2F4	chr3:22021506-22021698	MCF10A-Er-Src	breast:	n/a	n/a
17	E2F4	chr3:21995949-21996485	MCF10A-Er-Src	breast:	n/a	n/a
18	EBF1	chr3:21985565-21986097	GM12878	blood:	n/a	n/a
19	EP300	chr3:21996206-21996540	Hela-S3	cervix:	n/a	n/a
20	EP300	chr3:22030954-22031814	SK-N-SH	brain:	n/a	chr3:22031046-22031060
21	FAM48A	chr3:22032428-22032564	GM12878	blood:	n/a	n/a
22	FOS	chr3:22021191-22021624	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr3:21996984-21997174	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr3:22009897-22010001	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr3:22009928-22010025	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr3:21995955-21996602	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr3:21996160-21996599	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr3:21996172-21996566	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr3:22021248-22021614	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr3:22021191-22021572	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr3:21996970-21997170	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr3:22009885-22010052	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr3:21996203-21996529	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr3:22021192-22021594	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr3:22004212-22004269	MCF10A-Er-Src	breast:	n/a	n/a
36	FOXA1	chr3:22030040-22030358	HepG2	liver:	n/a	n/a
37	FOXA2	chr3:22029886-22030566	A549	lung:	n/a	n/a
38	FOXA2	chr3:22030065-22030400	A549	lung:	n/a	n/a
39	GATA2	chr3:22031220-22031795	SH-SY5Y	brain:	n/a	chr3:22031385-22031398
40	GATA3	chr3:22031161-22031535	SH-SY5Y	brain:	n/a	chr3:22031385-22031398 chr3:22031186-22031194
41	GATA3	chr3:22000365-22000565	SH-SY5Y	brain:	n/a	n/a
42	GATA3	chr3:22040561-22040748	SH-SY5Y	brain:	n/a	chr3:22040657-22040678
43	GATA3	chr3:22043731-22043843	SH-SY5Y	brain:	n/a	n/a
44	IRF1	chr3:22033460-22033502	K562	blood:	n/a	n/a
45	JUN	chr3:22011822-22012021	K562	blood:	n/a	n/a
46	JUN	chr3:22030961-22031169	HepG2	liver:	n/a	chr3:22031140-22031149 chr3:22031139-22031152
47	JUND	chr3:22036501-22036639	HepG2	liver:	n/a	n/a
48	MAFF	chr3:22013012-22013125	HepG2	liver:	n/a	chr3:22013095-22013113
49	MAFF	chr3:22035640-22035809	HepG2	liver:	n/a	chr3:22035742-22035760
50	MAFK	chr3:22035629-22035870	HepG2	liver:	n/a	chr3:22035743-22035759 chr3:22035743-22035758

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:22030381-22030431	HCT-116	colon:	n/a
2	chr3:22030381-22030431	HCM	heart:	n/a
3	chr3:22030381-22030431	HNPCEpiC	eye:	n/a
4	chr3:22030381-22030431	PFSK-1	brain:	n/a
5	chr3:22030381-22030431	AG04449	skin:	fetal
6	chr3:22030381-22030431	T-47D	breast:	n/a
7	chr3:22030381-22030431	SK-N-SH_RA	brain:	n/a
8	chr3:22030381-22030431	IMR90	lung:	fetal
9	chr3:22030381-22030431	HIPEpiC	eye:	n/a
10	chr3:22030381-22030431	AG10803	skin:	n/a
11	chr3:22030381-22030431	HCPEpiC	choroid plexus:	n/a
12	chr3:22030381-22030431	HAEpiC	amniotic membrane:	n/a
13	chr3:22030381-22030431	AG09309	skin:	n/a
14	chr3:22030381-22030431	U87	brain:	n/a
15	chr3:22030381-22030431	BE2_C	brain:	n/a
16	chr3:22030381-22030431	NT2-D1	testis:	n/a
17	chr3:22030381-22030431	K562	blood:	n/a
18	chr3:22030381-22030431	SK-N-MC	brain:	n/a
19	chr3:22030381-22030431	HCF	heart:	n/a
20	chr3:22030381-22030431	RPTEC	kidney:	n/a
21	chr3:22030381-22030431	Jurkat	blood:	n/a
22	chr3:22030381-22030431	HEEpiC	esophagus:	n/a
23	chr3:22030381-22030431	Hela-S3	cervix:	n/a
24	chr3:22030381-22030431	AG09319	gingival:	n/a
25	chr3:22030381-22030431	HRPEpiC	eye:	n/a
26	chr3:22030381-22030431	A549	lung:	n/a
27	chr3:22030381-22030431	GM19239	blood:	n/a
28	chr3:22030381-22030431	Hepatocyte	liver:	n/a
29	chr3:22030381-22030431	PANC-1	pancreas:	n/a
30	chr3:22030381-22030431	ovcar-3	ovarian:	n/a
31	chr3:22030381-22030431	BJ	skin:	n/a
32	chr3:22030381-22030431	HEK293	kidney:	embryo
33	chr3:22030381-22030431	ECC-1	luminal epithelium:	n/a
34	chr3:22030381-22030431	HepG2	liver:	n/a
35	chr3:22030381-22030431	HRCEpiC	kidney:	n/a
36	chr3:22030381-22030431	CMK	blood:	n/a
37	chr3:22030381-22030431	AG04450	lung:	fetal
38	chr3:22030381-22030431	LNCaP	prostate:	n/a
39	chr3:22030381-22030431	MCF10A-Er-Src	breast:	n/a
40	chr3:22030381-22030431	HUVEC	blood vessel:	n/a
41	chr3:22030381-22030431	GM12878	blood:	n/a
42	chr3:22030381-22030431	GM06990	blood:	n/a
43	chr3:22030381-22030431	GM12892	blood:	n/a
44	chr3:22030381-22030431	HPAEpiC	pulmonary alveolar:	n/a
45	chr3:22030381-22030431	HRE	kidney:	n/a
46	chr3:22030381-22030431	MCF-7	breast:	n/a
47	chr3:22030381-22030431	NHDF-neo	bronchial:	n/a
48	chr3:22030381-22030431	Caco-2	colon:	n/a
49	chr3:22030381-22030431	HL-60	blood:	n/a
50	chr3:22030381-22030431	NB4	blood:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:126141332..126144254-chr3:22001697..22003217,2	K562	blood:
2	chr3:22042480..22044020-chr3:22057123..22059814,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UBE2E2-2	chr3:22021123-22021320	ENSG00000223351
2	lnc-UBE2E2-2	chr3:22019707-22019783	ENSG00000223351
3	lnc-UBE2E2-2	chr3:22000324-22000415	ENSG00000223351
4	lnc-UBE2E2-2	chr3:21998628-21998684	ENSG00000223351
5	lnc-UBE2E2-2	chr3:22002908-22003032	ENSG00000223351
6	lnc-UBE2E2-2	chr3:21998631-21998684	ENSG00000223351
7	lnc-UBE2E2-2	chr3:22000324-22000415	ENSG00000223351

No data

Variant related genes	Relation type
ZNF385D-AS2	TF binding region
ZNF385D-AS2	CpG island
ENSG00000110074	chromatin interactions

Extended variants
information (count: 1992 )
Associated
traits (count: 72 )

Variant overlapped rSNPs/rCNVs (count:1992 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs519051	chr3:21985417-21985418	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs530936968	chr3:21985419-21985420	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs144381869	chr3:21985431-21985432	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs565925127	chr3:21985453-21985454	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs368012123	chr3:21985558-21985559	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs186236864	chr3:21985561-21985562	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs189870285	chr3:21985574-21985575	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs182069765	chr3:21985612-21985613	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs565986364	chr3:21985622-21985623	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs529994784	chr3:21985641-21985642	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs377088457	chr3:21985654-21985655	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs111567741	chr3:21985674-21985675	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs521724	chr3:21985691-21985692	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs148788193	chr3:21985701-21985702	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs558635467	chr3:21985764-21985765	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs34541965	chr3:21985765-21985766	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs522590	chr3:21985766-21985767	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs1684484	chr3:21985774-21985775	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs188274383	chr3:21985792-21985793	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs142468872	chr3:21985802-21985803	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs367606175	chr3:21985829-21985830	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs17582553	chr3:21985831-21985832	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs376806618	chr3:21985858-21985859	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs575810482	chr3:21985868-21985869	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs671377	chr3:21985871-21985872	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs564572080	chr3:21985885-21985886	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs192609058	chr3:21985887-21985888	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs141967828	chr3:21985890-21985891	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs183205082	chr3:21985891-21985892	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs555352742	chr3:21985895-21985896	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs529975005	chr3:21985898-21985899	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs144295831	chr3:21985922-21985923	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs9870712	chr3:21985925-21985926	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs147809634	chr3:21985926-21985927	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs551908341	chr3:21985928-21985929	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs570222826	chr3:21985929-21985930	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs534408749	chr3:21985939-21985940	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs35533533	chr3:21985946-21985947	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs552576779	chr3:21985958-21985959	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs375060348	chr3:21985968-21985969	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs568031817	chr3:21986008-21986009	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs188485764	chr3:21986055-21986056	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs562855720	chr3:21986071-21986072	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs192141055	chr3:21986104-21986105	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs575797877	chr3:21986113-21986114	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs185069058	chr3:21986118-21986119	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs140271927	chr3:21986137-21986138	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs558372190	chr3:21986157-21986158	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs150358252	chr3:21986194-21986195	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs35000541	chr3:21986234-21986235	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:72)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	18923191	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
lymphocytic leukemia	21291569	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Esophageal cancer	20955586	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Squamous cell cancer	20885788	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Melanoma	20688739	CNVD

Chromatin state (count:99 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:21982000-21987200	Weak transcription	Fetal Lung	lung
2	chr3:21984600-21985600	Weak transcription	NHDF-Ad	bronchial
3	chr3:21984600-21985800	Weak transcription	Fetal Heart	heart
4	chr3:21984600-21985800	Enhancers	Pancreatic Islets	Pancreatic Islet
5	chr3:21984600-21986000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr3:21984600-21996000	Weak transcription	Muscle Satellite Cultured Cells	--
7	chr3:21984800-21988400	Weak transcription	NHLF	lung
8	chr3:21985200-21986000	Active TSS	Fetal Stomach	stomach
9	chr3:21985200-21987400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr3:21985400-21985600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr3:21985400-21985800	Enhancers	Cortex derived primary cultured neurospheres	brain
12	chr3:21985400-21986200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr3:21985600-21985800	Enhancers	NHDF-Ad	bronchial
14	chr3:21985600-21986000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
15	chr3:21985600-21986000	Active TSS	Stomach Smooth Muscle	stomach
16	chr3:21985600-21986400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr3:21985800-21986200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
18	chr3:21985800-21986200	Enhancers	Fetal Heart	heart
19	chr3:21985800-21986200	Flanking Active TSS	NHDF-Ad	bronchial
20	chr3:21985800-21986400	Enhancers	Fetal Kidney	kidney
21	chr3:21985800-21986800	Weak transcription	Pancreatic Islets	Pancreatic Islet
22	chr3:21986000-21986200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr3:21986000-21986200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr3:21986000-21986200	Enhancers	NH-A	brain
25	chr3:21986000-21986600	Weak transcription	Fetal Stomach	stomach
26	chr3:21986200-21987200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr3:21986200-21987200	Weak transcription	NHDF-Ad	bronchial
28	chr3:21986400-21986800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
29	chr3:21986400-21986800	Weak transcription	Fetal Kidney	kidney
30	chr3:21986800-21987200	Enhancers	Pancreatic Islets	Pancreatic Islet
31	chr3:21986800-21987600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
32	chr3:21986800-21987600	Enhancers	Fetal Kidney	kidney
33	chr3:21987200-21987400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr3:21987200-21987400	Enhancers	Fetal Stomach	stomach
35	chr3:21987200-21987400	Enhancers	NHDF-Ad	bronchial
36	chr3:21987200-21987600	Enhancers	Fetal Lung	lung
37	chr3:21987400-21987600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr3:21987400-21993000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr3:21988400-21988600	Enhancers	NHLF	lung
40	chr3:21992800-21994000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr3:21993000-21993800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
42	chr3:21993200-21994000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr3:21994000-21994400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr3:21994400-21994800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr3:21995600-21995800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr3:21995800-21996800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr3:21995800-21997400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr3:21995800-21997800	Enhancers	Liver	Liver
49	chr3:21996000-21996400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr3:21996000-21997000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links